Piper Sandler Downgrades Traeger to Neutral, Lowers Price Target to $4
Piper Sandler analyst Peter Keith downgrades Traeger (NYSE:COOK) from Overweight to Neutral and lowers the price target from $6 to $4.
Citigroup Upgrades Truist Finl to Buy, Announces $52 Price Target
Citigroup analyst Keith Horowitz upgrades Truist Finl (NYSE:TFC) from Neutral to Buy and announces $52 price target.
BMO Capital Upgrades Apartment Income REIT to Market Perform, Announces $39 Price Target
BMO Capital analyst John Kim upgrades Apartment Income REIT (NYSE:AIRC) from Underperform to Market Perform and announces $39 price target.
Jefferies Upgrades Harley-Davidson to Hold, Announces $39 Price Target
Jefferies analyst Anna Glaessgen upgrades Harley-Davidson (NYSE:HOG) from Underperform to Hold and announces $39 price target.
JP Morgan Upgrades Hamilton Lane to Overweight, Announces $85 Price Target
JP Morgan analyst Kenneth Worthington upgrades Hamilton Lane (NASDAQ:HLNE) from Neutral to Overweight and announces $85 price target.
Needham Reiterates Buy on Super Group (SGHC), Maintains $5 Price Target
Needham analyst Bernie McTernan reiterates Super Group (SGHC) (NYSE:SGHC) with a Buy and maintains $5 price target.
Needham Maintains Buy on Cogent Biosciences, Lowers Price Target to $23
Needham analyst Ami Fadia maintains Cogent Biosciences (NASDAQ:COGT) with a Buy and lowers the price target from $24 to $23.
Needham Initiates Coverage On ShockWave Medical with Buy Rating, Announces Price Target of $240
Needham analyst Mike Matson initiates coverage on ShockWave Medical (NASDAQ:SWAV) with a Buy rating and announces Price Target of $240.
Canaccord Genuity Downgrades Q2 Holdings to Hold, Lowers Price Target to $25
Canaccord Genuity analyst Joseph Vafi downgrades Q2 Holdings (NYSE:QTWO) from Buy to Hold and lowers the price target from $60 to $25.
Telsey Advisory Group Reiterates Outperform on Grove Collaborative Hldgs, Maintains $3 Price Target
Telsey Advisory Group analyst Dana Telsey reiterates Grove Collaborative Hldgs (NYSE:GROV) with a Outperform and maintains $3 price target.